logo-loader
RNS
Frontier IP Group PLC

Exercise of Options and Total Voting Rights

RNS Number : 5966Y
Frontier IP Group plc
12 October 2026
 

AIM: FIPP

12 October 2026

 

Frontier IP Group Plc

("Frontier IP" or the "Group")

Exercise of Options and Total Voting Rights

Frontier IP (AIM: FIPP), a specialist in commercialising intellectual property, announces that a former director of the Company has exercised options to acquire 310,152 new ordinary shares of 10 pence each in the Company ("Ordinary Shares") pursuant to the terms of the Company's Employee Share Option Scheme 2011. These options were awarded in three different tranches on the following dates: 15 November 2018 (89,000 options), 6 December 2019 (173,333 options) and 5 November 2020 (47,819 options) and all options have an exercise price of 10p.

Accordingly, application has been made for 310,152 new Ordinary Shares to be admitted to trading on AIM (“Admission”). Admission is expected to occur at 8.00 a.m. on or around 13 October 2026.

The new Ordinary Shares will rank pari passu with the existing shares of the Company. Following Admission, the Company will have 112,615,058 Ordinary Shares in issue, with one voting right per Ordinary Share. The Company does not hold any Ordinary Shares in treasury, therefore the total number of voting rights in the Company is 112,615,058. Accordingly, the figure of 112,615,058 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA’s Disclosure Guidance and Transparency Rules

 

ENDS

 

ENQUIRIES

Frontier IP Group Plc

Neil Crabb, Chief Executive

 

Andrew Johnson, Communications & Investor Relations

Company website: www.frontierip.co.uk

 

 

neil@frontierip.co.uk

 

M: 07415 888 425

andrew.johnson@frontierip.co.uk

 

Allenby Capital Limited (Nominated Adviser and Joint Broker)

Nick Athanas / David Asquith (Corporate Finance)

Joscelin Pinnington / Matt Butlin (Corporate Broking)

 

T: 0203 328 5656

Shore Capital (Joint Broker)

Henry Willcocks (Corporate Broking)

James Thomas / George Payne (Corporate Advisory)

T: 0207 408 4050

 

 

About Frontier IP

Frontier IP unites science and commerce by identifying strong intellectual property and accelerating its development through a range of commercialisation services. A critical part of the Group's work is involving relevant industry partners at an early stage of development to ensure technology meets real world demands and needs.

The Group looks to build and grow a portfolio of equity stakes and licence income by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEMTBBTMTBBBTF
NO INVESTMENT ADVICE

Proactive Investors Australia Pty Ltd ACN 132 787 654 (the Company, we or us) provides you with access to the content set out above, including any news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) and this website (the Site) on the terms set out in this disclaimer, together with all other terms and conditions, disclaimers and other notices displayed elsewhere on this Site.

It is important for you to know that:

(a) none of the Content is, or is intended to be, general or personal advice

(b) the principal purpose of the Content is to provide factual information only and to comment on news;

(c) the Content does not contain or imply any recommendation or opinion intended to influence your financial decisions, including in respect of any particular security, portfolio of securities, transaction or investment strategy, and must not be relied upon by you as such;

(d) in providing you with the Content, we have not considered your objectives, financial situation or needs; and

(e) you should make your own enquiries and obtain your own independent advice prior to making any financial decisions.

The Content contains data (including but not limited to prices, statistics and calculated information) obtained from a variety of third party sources (Third Party Data). The Company does not make any representation or warranty that any of the Content, including the Third Party Data, will be reliable, accurate or complete. The Company disclaims all responsibility and liability arising in any way from any errors or omissions in the Content, including the Third Party Data, including any loss you may incur in connection with any action or decision made by you in reliance upon the Content or Third Party Data.

In certain circumstances the Company, its related bodies corporate, or their affiliates, may have received, or be entitled to receive, financial or other consideration in connection with providing information about certain entities on the Site, which may include the above Content.

FOR OUR FULL DISCLAIMER CLICK HERE

Frontier IP focused on further industrial engagement across portfolio

Neil Crabb, chief executive of Frontier IP Group Plc (LON:FIPP) caught up with Proactive's Andrew Scott following the release of their half-year report. Frontier’s portfolio includes AI drug researcher Exscientia which secured a €15mln strategic investment from drug discovery company...

on 29/3/18

3 min read